Added to YB: 2026-07-01
Pitch date: 2026-06-29
BNTX [neutral]
BioNTech SE
-1.38%
current return
Author Info
Value and Opportunity focuses on slow investing, special situations & the occasional wild punts Sign up for their newsletter.
Company Info
BioNTech SE, together with its subsidiaries, engages in the development and commercialization of immunotherapies in Germany.
Market Cap
$20.2B
Pitch Price
$94.35
Price Target
N/A
Dividend
N/A
EV/EBITDA
-5.94
P/E
-15.64
EV/Sales
2.43
Sector
Biotechnology
Category
special_situation
Special Situation 'Quickies': BioNTech SE
BNTX (watchlist): German biotech awaiting announcement on founder-company separation. Author flagged 3 months ago that failure to announce would be a bad sign. Stock stabilized/traded sideways since March departure news, with some volatility. Watching for now.
Read full article (1 min)